Esperion Therapeutics | ESPR - Ebit



Ebit Veränderung Datum
AbbVie USD 6.72B 1.99B 2026-06
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amarin USD -2.26M 564K 2025-12
Amgen USD 4.61B 777M 2026-06
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Cipla INR 8.88B 2.74B 2026-06
CSL USD 2.64B 116M 2025-12
Cytokinetics USD -179.17M 2.05M 2026-06
Daiichi Sankyo JPY 85.1B 4.44B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Geron USD -236K 10.55M 2026-03
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Merck USD 840M 2.72B 2026-06
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Moderna USD -815M 573M 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Pfizer USD -180M 5.16B 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sanofi EUR 1.12B 811M 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
United Therapeutics USD 375.6M 49.8M 2026-06
Vanda Pharmaceuticals USD -10.28M 721K 2024-12